PATENT CLAIM ANALYSIS

Application Number: 16283458
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["536", "024500"]

Abstract:
The. invention relates to a method for inducing or promoting skipping of exon 45 of DMD pre-mRNA in a Duchenne Muscular Dystrophy patient, preferably in an isolated (muscle) cell, the method comprising providing said cell with an antisense molecule that binds to a continuous stretch of at least 21 nucleotides within said exon. The invention further relates to such antisense molecule used in said method.

Claim (Index 18):
The oligonucleotide of  claim 16 , wherein the modification is a morpholino phosphorodiamidate modification.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 99.0
- Lexical Diversity: 1.46939
- Patent Class: 536.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14542183', '13094548', '14631686', '14859598', '12992218']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6556417726264779
- 35 USC 102 Novelty (BERT): 0.5752973124785656
- Combined Prediction Score: 0.6476073266116867
- Mean Citation Score: 343.41816000000006
- Max Citation Score: 363.4045
- Similarity Product: 299.3986514225006

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test